Drug Trial Radar · NCT02087306
Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection
Last checked: Nov 19, 2026Latest source record: Aug 13, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
201
Actual
Start
Mar 2014
Primary completion
Jun 2016
Study completion Aug 2016
Sponsor
- Lead sponsor
- Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
- Sponsor type
- Industry
- First posted
- Mar 14, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 2 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This was a Phase 3 open-label, non-randomized, multicenter study of oral brincidofovir (BCV) administered twice weekly for the treatment of adenovirus (AdV) infection detected during asymptomatic AdV viremia or during symptomatic AdV infection.
Conditions
- Adenovirus Infection
Interventions
BrincidofovirDrug
BCV administered twice weekly, dose depending on weight.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With All-Cause MortalityTime frame: 60 days
Locations
33 sites in 1 country. Site status is shown where the registry gives one.
Phoenix Children's Hospital
Phoenix, Arizona
Children's Hospital Los Angeles
Los Angeles, California
Stanford Children's Hospital
Palo Alto, California
Stanford University
Stanford, California
Children's Hospital Colorado
Aurora, Colorado
Children's National Health System
Washington D.C., District of Columbia
Children's Healthcare of Atlanta, Aflac Cancer and Blood Center
Atlanta, Georgia
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
University of Chicago
Chicago, Illinois
Children's Hospital
New Orleans, Louisiana
Johns Hopkins University
Baltimore, Maryland
Brigham and Woman's Hospital
Boston, Massachusetts
University of Minnesota
Minneapolis, Minnesota
Children's Mercy Hospital
Kansas City, Missouri
Washington University School of Medicine
St Louis, Missouri
University of Nebraska
Omaha, Nebraska
Memorial Sloan Kettering Cancer Center
New York, New York
Weill Cornell Medical College/ New York Presbyterian Hospital
New York, New York
Montifore Medical Center
The Bronx, New York
Levine Children's Hospital
Charlotte, North Carolina
Duke University Medical Center
Durham, North Carolina
Cincinnati Children's Hospital
Cincinnati, Ohio
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania
St. Jude Children's Hospital
Memphis, Tennessee
Cook Children's Medical Center
Fort Worth, Texas
Baylor College of Medicine
Houston, Texas
MD Anderson Cancer Center
Houston, Texas
Intermountain Healthcare Research
Salt Lake City, Utah
University of Utah Huntsman Cancer Institute
Salt Lake City, Utah
Fred Hutchingson Cancer Center
Seattle, Washington
Seattle Children's Hospital
Seattle, Washington
Medical College of Wisconsin
Milwaukee, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.